Welcome, everyone. I’m honored to host this series of imaginary conversations with some of the world’s most brilliant minds across science, technology, and sustainability. Together, we’ll explore how the revolutionary field of protein design is transforming our world—from medicine to global health, citizen science to cross-disciplinary innovation, and even the future of sustainability itself.
Protein design is more than just a scientific breakthrough; it’s a new frontier for solving humanity’s greatest challenges. It’s about designing life at the molecular level to address the most pressing issues of our time, such as curing diseases, combating climate change, and building equitable systems for a healthier, more sustainable future.
In this series, we’ll hear from experts in diverse fields, united by their shared vision of using science and innovation to improve lives. By bringing together their unique perspectives, I hope to spark new ideas, foster collaboration, and inspire action as we consider the profound potential of what’s possible.
Let’s embark on this journey together and dive into these fascinating conversations.
Revolutionizing Protein Design and Prediction
Participants: David Baker (Moderator), Frances Arnold, Demis Hassabis, Jennifer Doudna, Michael Levitt, Andre Geim
David Baker (Moderator):
Welcome, everyone. It’s an honor to be here with such brilliant minds. Today, we’re diving into the transformative world of protein design and prediction, a field that’s reshaping biology, medicine, and technology. Let’s start with a broad question: What excites you most about the future of computational approaches in science? Frances, would you like to begin?
Frances Arnold:
Thank you, David. I’m particularly excited about the convergence of computational methods with directed evolution. These tools allow us to guide evolution in ways nature never imagined. By simulating biological processes on a computer, we can test and refine thousands of possibilities before we ever enter the lab. This dramatically accelerates discovery and opens doors for sustainable industrial processes.
David Baker:
That’s fascinating, Frances. The idea of simulating evolution itself is so powerful. Demis, from your AI perspective, where do you see machine learning pushing the boundaries in protein design?
Demis Hassabis:
What excites me most is the ability of AI to predict protein folding with unprecedented accuracy, as we’ve seen with AlphaFold. But we’re only scratching the surface. AI could soon enable real-time, iterative design of proteins to address complex problems, from targeted therapies to bio-manufacturing. The computational power we now have is making the impossible possible.
David Baker:
That’s an inspiring vision, Demis. Jennifer, as someone working at the cutting edge of gene editing, how do you see advances in protein design impacting CRISPR and beyond?
Jennifer Doudna:
Great question, David. Protein design is already helping us enhance CRISPR systems, making them more precise and versatile. For instance, engineered Cas proteins can now target regions of DNA previously considered inaccessible. I also think protein design will play a role in creating entirely new tools for genome editing, ones we can’t even imagine today.
David Baker:
The potential to redesign nature itself is awe-inspiring. Michael, you’ve been a pioneer in molecular dynamics. How do you see your work integrating with these advancements?
Michael Levitt:
David, I think the beauty of computational protein design lies in its synergy with physics-based models. As we refine our understanding of molecular interactions, we can better predict how designed proteins will behave in real environments. This fusion of AI and physics is where I see the most exciting breakthroughs happening—turning theoretical models into practical applications.
David Baker:
I completely agree, Michael. That fusion of disciplines is what drives innovation. Andre, as someone who has worked in seemingly unrelated fields, what lessons from your research on graphene might apply to protein design?
Andre Geim:
That’s an intriguing question, David. What I’ve learned from graphene is that simplicity in design can yield extraordinary complexity in function. Proteins are like molecular machines, and I believe we can borrow from materials science to design proteins that are not only functional but also incredibly robust. Cross-disciplinary thinking is vital.
David Baker:
That’s a fantastic insight, Andre. It’s clear that cross-disciplinary collaboration will shape the future. To wrap up, I’d like each of you to share one bold prediction for the next decade in protein design. Frances?
Frances Arnold:
I predict we’ll see proteins designed to convert CO2 into useful products on an industrial scale, revolutionizing sustainability.
David Baker:
Demis?
Demis Hassabis:
I believe AI will enable the design of self-replicating protein systems, leading to a new era of synthetic biology.
David Baker:
Jennifer?
Jennifer Doudna:
We’ll develop proteins that can precisely edit RNA, unlocking treatments for diseases we currently can’t touch.
David Baker:
Michael?
Michael Levitt:
We’ll have a universal framework that integrates quantum mechanics and AI for designing proteins at atomic resolution.
David Baker:
Andre?
Andre Geim:
I foresee hybrid materials combining proteins and graphene-like structures for applications in nanotechnology and medicine.
David Baker:
Thank you all for such inspiring contributions. The future of protein design is in exceptional hands, and I look forward to seeing how your predictions shape our world. Let’s continue to push the boundaries of what’s possible!
Applications in Medicine and Global Health
Participants: David Baker (Moderator), Anthony Fauci, Emmanuelle Charpentier, Paul Farmer, Katalin Karikó, Atul Gawande
David Baker (Moderator):
Welcome, everyone. It’s a privilege to gather such a distinguished group to discuss how advances in protein design are revolutionizing medicine and global health. To begin, let’s look at the role of protein engineering in addressing public health challenges. Dr. Fauci, as someone who has led efforts against infectious diseases, where do you see its greatest potential?
Anthony Fauci:
Thank you, David. Protein engineering has already demonstrated its value in vaccine development, as we saw with COVID-19. The ability to design immunogens that precisely mimic viral structures will continue to be a game-changer for preventing pandemics. Beyond vaccines, I see potential in designing therapeutic proteins to modulate immune responses in diseases like HIV and autoimmunity.
David Baker:
That’s a powerful vision, Dr. Fauci. Emmanuelle, as a pioneer of CRISPR, how do you see protein design complementing gene editing technologies?
Emmanuelle Charpentier:
Thank you, David. Protein design is critical for expanding the functionality of CRISPR systems. By engineering Cas proteins, we can improve their specificity and reduce off-target effects. I also believe protein-based delivery systems will make genome editing safer and more efficient, especially for in vivo applications.
David Baker:
It’s incredible how these technologies are converging. Dr. Karikó, your work with mRNA has transformed medicine. How do you think protein design intersects with mRNA-based therapies?
Katalin Karikó:
Protein design is essential for optimizing the therapeutic proteins encoded by mRNA. For example, we can design proteins that fold more efficiently or have enhanced stability in the body. This not only improves efficacy but also broadens the range of diseases we can target with mRNA therapies.
David Baker:
Your insights are inspiring, Dr. Karikó. Dr. Farmer, you’ve spent your career focusing on health equity. How do you see these advancements impacting underserved populations?
Paul Farmer:
David, the key is affordability and accessibility. While protein-based treatments are transformative, they must be scalable for low-resource settings. I’m optimistic that advances in protein design can lead to simpler, more cost-effective therapies that address diseases like tuberculosis and malaria, which disproportionately affect the poor.
David Baker:
Accessibility is indeed crucial. Dr. Gawande, you’ve written extensively about improving healthcare systems. What role do you see for protein design in enhancing healthcare delivery?
Atul Gawande:
David, I believe protein engineering can simplify complex treatments. For instance, long-acting protein drugs could reduce the frequency of treatments for chronic conditions like diabetes or cancer. Moreover, engineered proteins could replace traditional diagnostics, enabling point-of-care tests that are faster and more reliable.
David Baker:
Excellent points, Dr. Gawande. Let’s pivot to the future. What do you all see as the biggest hurdles to realizing the potential of protein design in global health, and how can we overcome them? Dr. Fauci?
Anthony Fauci:
The biggest challenge is scaling up production while maintaining affordability. We need public-private partnerships to make advanced protein therapies accessible globally.
David Baker:
Emmanuelle?
Emmanuelle Charpentier:
I’d say regulatory frameworks need to evolve to keep pace with these innovations. We need faster, more flexible pathways for approving protein-based therapies.
David Baker:
Dr. Karikó?
Katalin Karikó:
Education is critical. We need to train the next generation of scientists to fully leverage the potential of protein design.
David Baker:
Dr. Farmer?
Paul Farmer:
Infrastructure in low-income countries must be prioritized. Without it, even the best innovations won’t reach those who need them most.
David Baker:
Dr. Gawande?
Atul Gawande:
I think communication is key. Public trust in science and technology is crucial for widespread adoption of protein-based treatments.
David Baker:
Thank you all for sharing such thoughtful perspectives. It’s clear that protein design holds immense promise for transforming global health. Our challenge now is to ensure that this promise translates into real-world impact for everyone, everywhere.
Citizen Science and Public Engagement
Participants: David Baker (Moderator), Carl Zimmer, Bill Nye, Brian Cox, Jocelyn Bell Burnell, Jane Goodall
David Baker (Moderator):
Welcome, everyone. Today, we’re exploring how citizen science and public engagement can accelerate scientific discovery and inspire a new generation of innovators. To start, Carl, as a science communicator, how do you see citizen science contributing to advancements in fields like protein design?
Carl Zimmer:
Thank you, David. Citizen science is about harnessing collective intelligence. Platforms like Rosetta@home are perfect examples of how the public can contribute to solving complex problems. By engaging non-scientists in tasks like protein folding, we not only speed up discoveries but also educate people about science in a hands-on way.
David Baker:
That’s a great point, Carl. Bill, you’ve spent your career making science fun and accessible. How do we inspire more people to get involved in projects like Rosetta@home?
Bill Nye:
Thanks, David. The key is storytelling. People connect with stories, not just data. When we show how protein design can lead to vaccines or renewable materials, we turn abstract concepts into relatable narratives. Add a little fun—like gamification—and you’ll see participation soar.
David Baker:
Storytelling and gamification are powerful tools. Brian, you’ve engaged millions with your documentaries. What role do you think media plays in fostering public participation in science?
Brian Cox:
Media is crucial, David. It’s a bridge between scientists and the public. Programs that showcase real-world impacts of projects like protein design can demystify the science and highlight its relevance. When people see themselves as part of the solution, they’re more likely to engage.
David Baker:
That’s so true, Brian. Jocelyn, you’ve been a role model for many aspiring scientists. What strategies can we use to ensure citizen science reaches underrepresented groups?
Jocelyn Bell Burnell:
Excellent question, David. Accessibility is key. We need to design citizen science platforms that are user-friendly and available in multiple languages. Outreach efforts should also focus on schools, libraries, and community centers to engage diverse populations, especially young people.
David Baker:
Inclusivity is vital. Jane, your work in conservation has inspired global participation. How do you see citizen science playing a role in other fields, like protein design or healthcare?
Jane Goodall:
Thank you, David. Citizen science is about empowerment. Just as people contribute to conservation by observing wildlife, they can contribute to healthcare by participating in distributed computing projects or donating data. It’s about showing people that their actions, no matter how small, make a difference.
David Baker:
Beautifully said, Jane. Let’s talk about the future. What steps should we take to expand citizen science and deepen its impact? Carl?
Carl Zimmer:
We need better communication between scientists and the public. Scientists must share their discoveries in accessible ways, so people understand how their contributions matter.
David Baker:
Bill?
Bill Nye:
Invest in education. If we teach kids about science in engaging ways, they’ll grow up eager to participate in citizen science projects.
David Baker:
Brian?
Brian Cox:
Leverage technology. Use AI to make citizen science more interactive and rewarding for participants.
David Baker:
Jocelyn?
Jocelyn Bell Burnell:
Focus on equity. Provide resources to underserved communities so they can participate fully in citizen science.
David Baker:
Jane?
Jane Goodall:
Build a sense of community. Show participants how their efforts connect with others around the world to create meaningful change.
David Baker:
Thank you all for your insights. Citizen science has the power to democratize discovery and bring people closer to the heart of scientific innovation. Together, we can ensure that this movement continues to grow and thrive.
Cross-Disciplinary Innovations and Biotechnology
Participants: David Baker (Moderator), Elon Musk, Fei-Fei Li, George Church, Ray Kurzweil, Manu Prakash
David Baker (Moderator):
Welcome, everyone. Today, we’re exploring how cross-disciplinary innovations are reshaping biotechnology and advancing fields like protein design. Each of you brings a unique perspective, so let’s begin with this: How can blending disciplines lead to breakthroughs in protein design? Elon, would you like to start?
Elon Musk:
Thanks, David. I think cross-disciplinary thinking is essential. In fields like space exploration, we’re already using biology to explore the possibilities of life support and sustainability on Mars. Protein design could help us create microbes that produce food, fuel, or oxygen in extreme environments. When you combine biology with engineering, the sky—or space—is no longer the limit.
David Baker:
Absolutely fascinating, Elon. Fei-Fei, as a pioneer in AI, how do you see machine learning transforming biotechnology?
Fei-Fei Li:
Thank you, David. Machine learning is accelerating discovery by uncovering patterns in biological data that humans might miss. In protein design, AI models like AlphaFold are solving problems that were considered impossible just a decade ago. The next step is integrating these models with real-world applications, such as personalized medicine or sustainable manufacturing.
David Baker:
The pace of AI-driven discovery is incredible. George, you’ve been at the forefront of synthetic biology. How do you see protein design evolving within this field?
George Church:
David, synthetic biology is all about designing life at its most fundamental level. Protein design is central to this, whether we’re creating enzymes to break down plastic or engineering proteins to cure genetic diseases. What excites me is the potential to program cells to produce entirely new materials or medicines on demand.
David Baker:
That’s a transformative vision, George. Ray, as a futurist, where do you see the intersection of protein design and emerging technologies taking us?
Ray Kurzweil:
David, I see a future where we merge biology and technology seamlessly. For example, we could design proteins that interface with nanotechnology to repair tissues or enhance cognitive functions. This convergence could lead to what I call the "Singularity of Biology," where biological innovation grows exponentially, driven by AI and protein engineering.
David Baker:
A singularity in biology—what a thought-provoking idea. Manu, you’ve developed incredible innovations in frugal science. How can protein design contribute to global challenges, especially in low-resource settings?
Manu Prakash:
Thank you, David. I believe in democratizing access to technology. Protein design can play a huge role here by creating low-cost diagnostic tools, like paper-based biosensors, that can be deployed anywhere. The key is to think not just about innovation but also about scalability and accessibility.
David Baker:
That’s such an important point, Manu. Let’s discuss the future. What’s the biggest barrier to integrating cross-disciplinary approaches in protein design, and how can we overcome it? Elon?
Elon Musk:
The biggest barrier is scaling innovation to practical applications. We need more collaboration between scientists, engineers, and entrepreneurs to turn ideas into reality.
David Baker:
Fei-Fei?
Fei-Fei Li:
A challenge is the complexity of biological systems. We need better AI models that can simulate these systems with greater accuracy and reliability.
David Baker:
George?
George Church:
Regulations often lag behind innovation. We need policies that support experimentation while ensuring safety and ethical responsibility.
David Baker:
Ray?
Ray Kurzweil:
Education is critical. We need interdisciplinary training programs that equip the next generation with skills in biology, AI, and engineering.
David Baker:
Manu?
Manu Prakash:
Equity is the biggest challenge. We must ensure that the benefits of protein design are shared globally, not just concentrated in wealthy nations.
David Baker:
Thank you all for your insightful contributions. The future of biotechnology lies in collaboration across disciplines, and together, we can unlock solutions to some of humanity’s greatest challenges.
Vision for Sustainability and the Future
Participants: David Baker (Moderator), Al Gore, Naomi Oreskes, Craig Venter, E.O. Wilson, Jeffrey Sachs
David Baker (Moderator):
Thank you all for joining this important conversation. Today, we’re discussing how advances in protein design can contribute to sustainability and a better future. To start, Al, you’ve been a global voice on climate change. How do you see protein design playing a role in combating environmental challenges?
Al Gore:
Thank you, David. Protein design can help address climate change in several ways. For example, we can engineer enzymes to break down plastics, reducing pollution. Proteins could also be designed to create carbon-neutral biofuels or capture CO2 directly from the atmosphere. These innovations are crucial as we strive to achieve net-zero emissions.
David Baker:
That’s inspiring, Al. Naomi, you’ve studied how scientific innovation intersects with societal change. What do you think is the key to ensuring protein design innovations have a global impact?
Naomi Oreskes:
The key is trust and transparency. Scientific breakthroughs often face public skepticism, so it’s essential to communicate the benefits clearly and address ethical concerns. Protein design must also be tied to broader sustainability efforts, like reducing reliance on fossil fuels and improving food security.
David Baker:
Excellent point, Naomi. Craig, as a pioneer in genomics and synthetic biology, how do you envision protein design contributing to a sustainable future?
Craig Venter:
David, protein design allows us to reprogram life itself. We can create microbes that produce biodegradable materials or proteins that enhance crop resilience to climate change. My team is also exploring how engineered proteins can clean up oil spills or purify water, making sustainability efforts more efficient and scalable.
David Baker:
Your work is truly transformative, Craig. E.O., your expertise in biodiversity brings a unique perspective. How can protein design support conservation and ecosystems?
E.O. Wilson:
Thank you, David. Protein design has the potential to restore balance in ecosystems. For example, we could develop proteins that neutralize invasive species without harming native ones or enhance the resilience of endangered species. However, we must proceed with caution to ensure these interventions don’t disrupt ecological harmony.
David Baker:
Wise words, E.O. Jeffrey, you’ve worked on sustainable development globally. How do we ensure that the benefits of protein design reach all nations, especially developing ones?
Jeffrey Sachs:
Great question, David. It starts with collaboration. Wealthy nations and institutions must invest in making protein design accessible to developing countries. This means funding research, sharing technologies, and creating frameworks for equitable distribution of innovations, like drought-resistant crops or low-cost diagnostics.
David Baker:
Equity and accessibility are recurring themes. Let’s discuss the future. What bold prediction do you have for how protein design will transform sustainability by 2035? Al?
Al Gore:
I predict protein design will make biofuels and biodegradable materials mainstream, drastically reducing our reliance on fossil fuels and single-use plastics.
David Baker:
Naomi?
Naomi Oreskes:
I believe protein design will revolutionize agriculture, with engineered crops and enzymes enabling us to feed a growing population sustainably.
David Baker:
Craig?
Craig Venter:
By 2035, we’ll have microbial factories producing everything from medicines to building materials, powered entirely by renewable resources.
David Baker:
E.O.?
E.O. Wilson:
I see protein design playing a role in rewilding efforts, helping to restore ecosystems and protect biodiversity on a massive scale.
David Baker:
Jeffrey?
Jeffrey Sachs:
I predict protein design will become a cornerstone of global health and sustainability initiatives, reducing inequality and improving quality of life worldwide.
David Baker:
Thank you all for such forward-thinking perspectives. It’s clear that protein design holds incredible promise for building a sustainable and equitable future. Our task now is to ensure these innovations benefit everyone and protect our planet.
Short Bios:
David Baker: Renowned biochemist and director of the Institute for Protein Design, known for pioneering computational protein design and leading innovations in molecular biology.
Frances Arnold: Nobel Laureate in Chemistry for her groundbreaking work on the directed evolution of enzymes, advancing sustainable industrial chemistry.
Demis Hassabis: AI pioneer and founder of DeepMind, known for creating AlphaFold, which revolutionized protein structure prediction.
Jennifer Doudna: Nobel Laureate for co-discovering CRISPR-Cas9, a transformative gene-editing technology used in medicine and agriculture.
Michael Levitt: Nobel Laureate in Chemistry for his contributions to molecular dynamics and computational biology.
Andre Geim: Nobel Laureate in Physics for the discovery of graphene, a versatile material, and an advocate for cross-disciplinary scientific exploration.
Anthony Fauci: Renowned immunologist and global health leader, instrumental in addressing major pandemics such as HIV/AIDS and COVID-19.
Emmanuelle Charpentier: Nobel Laureate for co-developing CRISPR-Cas9, enabling precision gene editing for therapeutic applications.
Paul Farmer: Global health advocate and founder of Partners in Health, dedicated to bringing innovative medical solutions to underserved populations.
Katalin Karikó: Biochemist and co-developer of mRNA technology, critical to the rapid development of COVID-19 vaccines.
Atul Gawande: Surgeon, author, and public health leader, focused on improving healthcare delivery and global health systems.
Carl Zimmer: Acclaimed science writer and journalist, known for making complex biological concepts accessible to the public.
Bill Nye: Science communicator and educator, inspiring public engagement in science through his work as "The Science Guy."
Brian Cox: Physicist and media presenter, recognized for his ability to popularize scientific concepts through engaging documentaries.
Jocelyn Bell Burnell: Astrophysicist credited with discovering pulsars and a champion for diversity and public involvement in science.
Jane Goodall: Renowned primatologist and conservationist, inspiring global action through her work with wildlife and community-led conservation.
Elon Musk: Entrepreneur and innovator, known for advancing technologies in space exploration, renewable energy, and artificial intelligence.
Fei-Fei Li: AI researcher and former director of Stanford’s AI Lab, specializing in machine learning applications for societal benefits.
George Church: Geneticist and synthetic biologist, leading efforts in genome engineering and biotechnology for sustainability and medicine.
Ray Kurzweil: Futurist and inventor, known for his vision of technological convergence and advancements in artificial intelligence and biology.
Manu Prakash: Biophysicist and inventor, recognized for creating low-cost scientific tools and championing frugal science for global health.
Al Gore: Former U.S. Vice President and Nobel Peace Prize winner, advocating for climate action and environmental sustainability.
Naomi Oreskes: Historian of science, specializing in the societal impacts of scientific innovations and the communication of climate science.
Craig Venter: Genomics pioneer and synthetic biologist, known for sequencing the human genome and creating synthetic life forms.
E.O. Wilson: Late biologist and conservationist, a leading advocate for biodiversity and ecological preservation.
Jeffrey Sachs: Economist and global development expert, focusing on sustainability and equitable access to innovation.
Leave a Reply